We are proud to announce their 2nd Annual Wearable Injectors and Connected Devices USA Conference taking place on the 8th and 9th of September 2025.
As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices.
As part of our leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2025!
2025 Speakers
- Anjana Wills, Head of Device Combination Products and Software Quality, AstraZeneca
- Cheng Yang, Digital Diagnostics Lead, Drug Product and Device Development, R&D, Takeda
- Cindy Tritton, Project Lead, Senior Engineer III, Technical Development, Biogen
- Confirmed Senior Representative, BioPhorum
- Deep Bhattacharya, Principal Scientist Formulation and Process Development - Biotherapeutics, Pfizer
- Ellie Younger, Associate Principal Engineer, AstraZeneca
- George Currier, Senior Principal Scientist, Device Development, Bristol Myers Squibb
- Harry Jiang, Device Engineering Lead, Alexion Pharmaceuticals
- Khaudeja Bano, Vice President - Global Head of Device Quality, Roche-Genentech
- Lipa Shah, Director Science and Technology, Novartis Pharmaceuticals Inc
- Mark Harycki, Senior Director, Device Portfolio and Program Management, Eli Lilly and Company
- Michael Price, Associate Director, Human Factors, AstraZeneca
- Paul Upham, Global Head of Smart Devices, Roche-Genentech
- Prasad Peri, AVP Regualtory Affairs Connected Delivery, Devices and Digital Health, Eli Lilly
- Sharmad Joshi, Senior Engineer II Device Development, Alexion AstraZeneca Rare Disease
- Shruti Parikh, Director, Product Design, Takeda Pharmaceuticals
- Sriram Natarjaan, Sr. Manager, Product Quality Management, Johnson & Johnson
- Yvette Appleby, Senior Manager, Digital Health & PMO, Pfizer
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Courtyard by Marriott Boston Downtown
275 Tremont St, 02116
Boston, MA, USA
